How cells manage protein production during stress
Understanding mRNA Condensation and Its Role in Translational Control during Stress
This study looks at how yeast cells manage to make important proteins when they're under stress from heat, focusing on how certain messages in the cells get organized to help them respond better to tough situations.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11059077 on NIH RePORTER |
What this research studies
This research investigates how cells control the production of proteins in response to stress, particularly focusing on the condensation of messenger RNA (mRNA) and its role in regulating translation. By examining over 5,000 genes in yeast during temperature stress, the study aims to identify which mRNAs condense and the mechanisms behind this process. The researchers will utilize biochemical techniques and RNA sequencing to gather data that could reveal how cells prioritize the production of protective proteins when faced with environmental challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by Alzheimer's disease or related dementias, particularly those experiencing stress-related symptoms.
Not a fit: Patients with non-neurological conditions or those not affected by Alzheimer's or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing cellular resilience in diseases like Alzheimer's, potentially improving patient outcomes.
How similar studies have performed: While the specific approach of studying mRNA condensation in stress response is novel, related research has shown success in understanding cellular stress responses and their implications for diseases.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Glauninger, Hendrik — University of Chicago
- Study coordinator: Glauninger, Hendrik
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.